Movement Alert｜MEDBOT-B Rises 5.5% in Regular Trading, Broker Initiates Buy Rating After Post-Profit-Alert Pullback Digestion

Market Focus07-31

On July 31, MEDBOT-B rose 5.5% in regular trading, trading at approximately 21.08 HKD/share, with turnover of 46.56 million HKD. The stock had previously pulled back approximately 5% over two consecutive sessions following its profit alert rally, with short-term profit-taking now largely absorbed.

On the news front, Dahua Capital yesterday initiated coverage on the company with a Buy rating and a target price of 29 HKD, providing support for the rebound. Fundamentally, the company achieved its first-ever half-year profit, expecting net profit of RMB 28-40 million for H1, with revenue surging 200%-230% year-over-year. Its core Toumai surgical robot saw overseas revenue growth exceeding 450%, while overall gross margin improved by more than 15 percentage points.

Within the Health Care Equipment sector, broader sentiment recovered, with MICROPORT up 2.69% and LIFETECH SCI up 3.57%, as sector-wide fund inflows supported constituent names.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1140230160?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 10:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140230160","market":"hk","top_or_hot":-1,"title":"Movement Alert｜MEDBOT-B Rises 5.5% in Regular Trading, Broker Initiates Buy Rating After Post-Profit-Alert Pullback Digestion","media":"Market Focus","content":"<p><p>On July 31, MEDBOT-B rose 5.5% in regular trading, trading at approximately 21.08 HKD/share, with turnover of 46.56 million HKD. The stock had previously pulled back approximately 5% over two consecutive sessions following its profit alert rally, with short-term profit-taking now largely absorbed.</p><p>On the news front, Dahua Capital yesterday initiated coverage on the company with a Buy rating and a target price of 29 HKD, providing support for the rebound. Fundamentally, the company achieved its first-ever half-year profit, expecting net profit of RMB 28-40 million for H1, with revenue surging 200%-230% year-over-year. Its core Toumai surgical robot saw overseas revenue growth exceeding 450%, while overall gross margin improved by more than 15 percentage points.</p><p>Within the Health Care Equipment sector, broader sentiment recovered, with MICROPORT up 2.69% and LIFETECH SCI up 3.57%, as sector-wide fund inflows supported constituent names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜MEDBOT-B Rises 5.5% in Regular Trading, Broker Initiates Buy Rating After Post-Profit-Alert Pullback Digestion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜MEDBOT-B Rises 5.5% in Regular Trading, Broker Initiates Buy Rating After Post-Profit-Alert Pullback Digestion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-31 10:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 31, MEDBOT-B rose 5.5% in regular trading, trading at approximately 21.08 HKD/share, with turnover of 46.56 million HKD. The stock had previously pulled back approximately 5% over two consecutive sessions following its profit alert rally, with short-term profit-taking now largely absorbed.</p><p>On the news front, Dahua Capital yesterday initiated coverage on the company with a Buy rating and a target price of 29 HKD, providing support for the rebound. Fundamentally, the company achieved its first-ever half-year profit, expecting net profit of RMB 28-40 million for H1, with revenue surging 200%-230% year-over-year. Its core Toumai surgical robot saw overseas revenue growth exceeding 450%, while overall gross margin improved by more than 15 percentage points.</p><p>Within the Health Care Equipment sector, broader sentiment recovered, with MICROPORT up 2.69% and LIFETECH SCI up 3.57%, as sector-wide fund inflows supported constituent names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1140230160","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140230160","pubTimestamp":1785466709,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 31, MEDBOT-B rose 5.5% in regular trading, trading at approximately 21.08 HKD/share, with turnover of 46.56 million HKD. The stock had previously pulled back approximately 5% over two...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"走势警报|MEDBOT-B 在常规交易中上涨 5.5%，经纪商在盈利警报回调消化后启动买入评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"On July 31, MEDBOT-B rose 5.5% in regular trading, trading at approximately 21.08 HKD/share, with turnover of 46.56 million HKD. The stock had previously pulled back approximately 5% over two consecutive sessions following its profit alert rally, with short-term profit-taking now largely absorbed.On the news front, Dahua Capital yesterday initiated coverage on the company with a Buy rating and a target price of 29 HKD, providing support for the rebound. Fundamentally, the company achieved its first-ever half-year profit, expecting net profit of RMB 28-40 million for H1, with revenue surging 200%-230% year-over-year. Its core Toumai surgical robot saw overseas revenue growth exceeding 450%, while overall gross margin improved by more than 15 percentage points.Within the Health Care Equipment sector, broader sentiment recovered, with MICROPORT up 2.69% and LIFETECH SCI up 3.57%, as sector-wide fund inflows supported constituent names.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1140230160","isCrawlerRequest":true}